Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panobinostat and Bicalutamide in Recurrent Prostate Cancer
NCT00878436Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Jun 2009
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of panobinostat in castration-resistant prostate cancer (CRPC), sponsored by NYU Langone Health. Started Jun 2009; status: completed.
02
Drugs
panobinostat
03
Conditions
castration-resistant prostate cancer (CRPC)
Beyond the preview
Go deeper on NCT00878436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00878436.